Evidence map›Paper›PMID 36090977›Full record

ArticleFrontiers in immunology2022

Mucosal immune and stress responses of

Carlo C Lazado, David A Strand, Mette W Breiland, Francisco Furtado, Gerrit Timmerhaus, Mona C Gjessing, Sigurd Hytterød, Grigory V Merkin, Lars-Flemming Pedersen, Karin A Pittman and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Carlo C LazadoNofima, The Norwegian Institute of Food, Fisheries and Aquaculture Research, Ås, Norway.
David A StrandNorwegian Veterinary Institute, Ås, Norway.
Mette W BreilandNofima, The Norwegian Institute of Food, Fisheries and Aquaculture Research, Tromsø, Norway.
Francisco FurtadoNofima, The Norwegian Institute of Food, Fisheries and Aquaculture Research, Ås, Norway.
Gerrit TimmerhausNofima, The Norwegian Institute of Food, Fisheries and Aquaculture Research, Ås, Norway.
Mona C GjessingNorwegian Veterinary Institute, Ås, Norway.
Sigurd HytterødNorwegian Veterinary Institute, Ås, Norway.
Grigory V MerkinQuantidoc AS, Bergen, Norway.
Lars-Flemming PedersenDTU Aqua, Section for Aquaculture, The North Sea Research Centre, Technical University of Denmark, Hirtshals, Denmark.
Karin A PittmanQuantidoc AS, Bergen, Norway.
Aleksei KrasnovNofima, The Norwegian Institute of Food, Fisheries and Aquaculture Research, Ås, Norway.
Nofima · NONorwegian Veterinary Institute · NOTechnical University of Denmark · DKUniversity of Bergen · NOUniversity of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment development for parasitic infestation is often limited to disease resolution as an endpoint response, and physiological and immunological consequences are not thoroughly considered. Here, we report the impact of exposing Atlantic salmon affected with amoebic gill disease (AGD) to peracetic acid (PAA), an oxidative chemotherapeutic. AGD-affected fish were treated with PAA either by exposing them to 5 ppm for 30 min or 10 ppm for 15 min. Unexposed fish from both infected and uninfected groups were also included. Samples for molecular, biochemical, and histological evaluations were collected at 24 h, 2 weeks, and 4 weeks post-treatment. Behavioral changes were observed during PAA exposure, and post-treatment mortality was higher in the infected and PAA treated groups, especially in 10 ppm for 15 min. Plasma indicators showed that liver health was affected by AGD, though PAA treatment did not exacerbate the infection-related changes. Transcriptome profiling in the gills showed significant changes, triggered by AGD and PAA treatments, and the effects of PAA were more notable 24 h after treatment. Genes related to immune pathways of B- and T- cells and protein synthesis and metabolism were downregulated, where the magnitude was more remarkable in 10 ppm for 15 min group. Even though treatment did not fully resolve the pathologies associated with AGD, 5 ppm for 30 min group showed lower parasite load at 4 weeks post-treatment. Mucous cell parameters (i.e., size and density) increased within 24 h post-treatment and were significantly higher at termination, especially in AGD-affected fish, with some treatment effects influenced by the dose of PAA. Infection and treatments resulted in oxidative stress-in the early phase in the gill mucosa, while systemic reactive oxygen species (ROS) dysregulation was evident at the later stage. Infected fish responded to elevated circulating ROS by increasing antioxidant production. Exposing the fish to a crowding stress revealed the interference in the post-stress responses. Lower cortisol response was displayed by AGD-affected groups. Collectively, the study established that PAA, within the evaluated treatment protocols, could not provide a convincing treatment resolution and, thus, requires further optimization. Nonetheless, PAA treatment altered the mucosal immune and stress responses of AGD-affected Atlantic salmon, shedding light on the host-parasite-treatment interactions.  .

Indexed as

ParasitesSalmo salarAmebiasisAnimalsFish DiseasesMucous MembraneOxidantsPeracetic AcidReactive Oxygen SpeciesOxidantsPeracetic AcidReactive Oxygen Speciesamoebic gill diseaseaquaculturefish healthgill healthmucosal immunitymucous cellsoxidative stressparasitic infection

Identifiers

PMID36090977
PMCPMC9454302
OpenAlexW4293052184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.